Sungen to Showcase China's Innovative Power at JPM 2026
The 44th J.P. Morgan Healthcare Conference (JPM 2026), the world's premier healthcare partnership and investment forum, will convene in San Francisco from January 12 to 15, 2026. Beijing Sungen Bi...
2026China FIC Innovation & Collaboration Sumit
TIME: Sunday, Jan 11,2026ADDRESS: Hyatt Regency San Francisco Downtown SOMA Keynote Speech: High-Quality Clinical Trials Underpinning Innovative Drug Developmeng: Development of SGC001, the First-in-W...
CHINADAILY | US-China biotech summit builds bridges for innovative drug partners
The 2026 China FIC Innovation and Collaboration Summit is held on Sunday in San Francisco. The summit, hosted by the Zhongguancun First-in-Class Innovative Drug Global Strategic Development Alliance, ...
2026 JPM Focus Series | Focusing on CTLA4 dual-target innovative platform, Sungen Released Preclinical Results of Anti-Tumor Therapeutic Bspecific Antibody SGT003 in cancer treatment for the first time
From January 12th to 15th, Pacific Time, the 44th J.P. Morgan Healthcare Conference was grandly held in San Francisco, USA. As a "bellwether" in the global biopharmaceutical field, this conf...
2026 China FIC Innovation and Collaboration Summit Held in San Francisco, Chinese Pharmaceutical Companies Showcase Innovative Achievements
SAN FRANCISCO, Jan. 16, 2026 /PRNewswire/ --During the 2026 J.P. Morgan Healthcare Conference (JPM), the 2026 China FIC Innovation & Collaboration Summit was successfully held in San Francisco, th...
Sungen BioMed Unveils Next-Generation “SG Linker-Payload” Platform for ADC Development at 2026 J.P. Morgan Healthcare Conference
Following the successive announcements of significant progress in its first-in-class antibody drug SGC001 for acute myocardial infarction and next-generation immuno-oncology pipeline SGT003, Sungen Bi...
